Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Titan Pharma (NQ: TTNP )

4.240 +0.240 (+6.00%)
Streaming Delayed Price Updated: 11:17 AM EST, Nov 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Titan Pharma

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITI, TTNP, FRZA on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Iteris, Inc. (Nasdaq - ITI), Forza X1, Inc. (Nasdaq - FRZA), Titan Pharmaceuticals, Inc. (Nasdaq - TTNP), Gatos Silver, Inc. (NYSE - GATO)
From Brodsky & Smith LLC
Via GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CFB, SDIG, TTNP on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BALY, K, TTNP on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
TITAN PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Titan Pharmaceuticals, Inc. - TTNP
From Kahn Swick & Foti, LLC
Via Business Wire
TTNP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Titan Pharmaceuticals, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Titan Pharmaceuticals Provides Shareholder Update
From Titan Pharmaceuticals, Inc.
Via GlobeNewswire
UPDATE -- Titan Pharmaceuticals Inc. Announces Licensing Agreement with Ocular Therapeutix Inc.
From Titan Pharmaceuticals, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.